Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 8:56 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 697–720 of 17,841 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Patient Control Clear all

Conditions: Obesity, Weight Loss, CHD - Coronary Heart Disease
Interventions: Exercise, Health Education, Exercise Compliance, Calorie-Restricted Diet, Behavioral Modification, Weight-Loss Compliance, Dietary Counseling; Other · Behavioral · Dietary Supplement
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 40 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Parkinson Disease
Interventions: Procedure/Surgery: Response Inhibition and Deep Brain Stimulation in Parkinson's disease; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Pediatric Obesity, Pediatric Overweight, Overweight , Obesity
Interventions: Get Up & Go Healthy Lifestyle Program; Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 6 Years to 14 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Immune-related Colitis
Interventions: Methoxsalen, Infliximab, Vedolizumab; Drug
Lead sponsor: Therakos LLC; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Caregiver Burden, Cognitive Impairment, Dementia, Alzheimer Disease, Pain, Chronic
Interventions: Pain Identification and Communication Toolkit, Health Promotion Program; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 21 Years and older
Enrollment: 440 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Spinocerebellar Ataxias, Cerebellar Ataxia, Nucleotide Repeat Disease
Interventions: Specimen collection; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Diabetic Foot Ulcers
Interventions: Antimicrobial Peptide PL-5 Topical Spray and Placebo; Drug
Lead sponsor: Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 3
States / cities: Vista, California • Miami, Florida • Tampa, Florida

Conditions: Sensorineural Hearing Loss, Noise Induced Hearing Loss, Sudden Sensorineural Hearing Loss
Interventions: FX-322 (One Dose), FX-322 (Two Doses), FX-322 (Four Doses), Placebo; Drug
Lead sponsor: Frequency Therapeutics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 16
States / cities: Fresno, California • Torrance, California • Colorado Springs, Colorado + 12 more

Conditions: Mycobacterium Avium Complex, Non-tuberculous Mycobacterium Pulmonary Disease
Interventions: SPR720, Placebo, Open-label Standard of Care; Drug
Lead sponsor: Spero Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 9
States / cities: Altamonte Springs, Florida • Atlantis, Florida • Clearwater, Florida + 6 more

Conditions: Post Abdominal Surgery Pain
Interventions: CR845 IV 1 mcg/kg, CR845 IV 0.5 mcg/kg, Placebo IV; Drug
Lead sponsor: Cara Therapeutics, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 451 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 23
States / cities: Sheffield, Alabama • New Haven, Connecticut • Bradenton, Florida + 20 more

Conditions: Fibromyalgia
Interventions: pregabalin, placebo; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 441 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 30
States / cities: Orange, California • Santa Ana, California • Ocala, Florida + 27 more

Conditions: Schizophrenia, Metabolic Syndrome X, Insulin Resistance
Interventions: Switch, Control; Drug
Lead sponsor: Veterans Medical Research Foundation; Other
Eligibility: 18 Years to 65 Years
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: San Diego, California

Conditions: Depression
Interventions: NSI-189 Phosphate, microcrystalline cellulose capsules; Drug
Lead sponsor: Neuralstem Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Glendale, California

Conditions: Nasal Polyposis
Interventions: AK001 low dose, AK001 high dose, Placebo; Drug
Lead sponsor: Allakos Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 5
States / cities: Chicago, Illinois • Boston, Massachusetts • Pittsburgh, Pennsylvania + 2 more

Conditions: Pain
Interventions: Stationary Bike, Virtual Reality (VR) Headset, Ice Bath; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 151 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Pain, Post-operative
Interventions: Ropivacaine 0.35%; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Rheumatoid Arthritis
Interventions: CFZ533, Placebo; Biological · Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 5
States / cities: Anniston, Alabama • Miami, Florida • South Miami, Florida + 2 more

Conditions: Asthma in Children
Interventions: AsthmaTuner, Asthma-Guidance and Prediction System; Device · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 6 Years to 17 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Alzheimer' Disease
Interventions: Provider Educational Intervention; Other
Lead sponsor: Florida Atlantic University; Other
Eligibility: 50 Years and older
Enrollment: 336 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Belle Glade, Florida • Boca Raton, Florida

Conditions: Congestive Heart Failure
Interventions: Health Literacy-Tailored Education; Behavioral
Lead sponsor: Griffin Hospital; Other
Eligibility: 50 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Derby, Connecticut

Conditions: Asthma, Chronic Sinusitis
Interventions: Endoscopic Sinus Surgery, medical therapy; Procedure · Other
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Parent-Child Relations, Cancer, Survivorship, Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm, Parent-Child Relation, Parenting
Interventions: Group 1: Educational counseling intervention, Group II Active Comparator; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 23 Years to 68 Years
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Seattle, Washington

Conditions: Kidney Transplantation, Delayed Graft Function
Interventions: CellCept; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis
Interventions: Non-Interventional Study; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 40 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

Targeting Obesity to Optimize Health in Cardiac Rehab (TOPCARE)

Investigating Inhibitory Control Networks in Parkinson's Disease

Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program

EPIC- Extracorporeal Photopheresis (ECP) for Immune-related Colitis

Evaluating the Efficacy of the Pain Identification and Communication Toolkit

Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases

Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers

FX-322 in Adults With Stable Sensorineural Hearing Loss

Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease

A Study Evaluating the Overall Pain Relief and Safety of Intravenous (IV) CR845 in Patients Undergoing Abdominal Surgery

Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients

Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes

Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects

Study to Evaluate Multiple Doses in Patients With Nasal Polyposis

Stationary Bike Use During Ice Bath and Virtual Reality

Serratus Anterior Plane Block in Patients Undergoing Mastectomy

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients

A Study of Remote Asthma Management Using an Integrated Artificial Intelligence-assisted EHR Dashboard and Mobile Device Compared With Usual Asthma Care to Treat 6-17 Year Old Patients

Optimizing Rural Community Health Through Dementia Detection and Care

Health Literacy in Patients With Congestive Heart Failure

Effects of Endoscopic Sinus Surgery for Chronic Sinusitis on Asthma Control

Cancer Parenting Program for the Enhancement of the Quality of Life of Patients With Advanced Cancer and Their Children

A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors

Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects